Treatment of Subconjunctival Hemorrhage
Most cases of subconjunctival hemorrhage (bleeding under the sclera) are benign and self-limiting, requiring only observation and reassurance as they typically resolve spontaneously within 1-2 weeks without specific treatment.
Initial Management
- Subconjunctival hemorrhage appears as a bright red patch on the white of the eye, often without pain or visual disturbance 1
- For typical cases, observation is the primary approach with reassurance that the condition will resolve on its own 1
- Bilateral patching and/or elevation of the head while sleeping may help clear the hemorrhage more quickly 2, 3
- Artificial tears can be used to reduce any associated irritation or foreign body sensation 4
Evaluation for Underlying Causes
For first-time, isolated subconjunctival hemorrhage, detailed history should focus on:
- Recent trauma (accounts for 83% of cases in children) 5
- Contact lens usage (common risk factor in younger patients) 1
- Valsalva maneuvers (coughing, vomiting, heavy lifting) 6
- Systemic vascular diseases (hypertension, diabetes, arteriosclerosis) 1
- Current medications (anticoagulants, antiplatelets, NSAIDs) 6
For recurrent or bilateral subconjunctival hemorrhages, further evaluation is warranted:
When to Refer to a Specialist
Immediate ophthalmology referral is indicated for:
Hematology referral may be necessary for:
Treatment Based on Underlying Cause
For trauma-related subconjunctival hemorrhage:
For anticoagulant-related hemorrhage:
For hypertension-related hemorrhage:
Surgical Considerations
- Surgery is rarely indicated for isolated subconjunctival hemorrhage 4
- In cases where subconjunctival hemorrhage is associated with vitreous hemorrhage:
Complications and Follow-up
- Most subconjunctival hemorrhages resolve without complications within 2 weeks 1
- Patients should be advised to return if:
Special Considerations
- In children, subconjunctival hemorrhage is uncommon (prevalence 0.4%) and most cases (83%) are due to trauma 5
- In rare cases, subconjunctival hemorrhage can be the first presenting sign of serious systemic disorders like idiopathic thrombocytopenic purpura 7
- The prevalence of hemostatic alterations in patients with recurrent spontaneous subconjunctival hemorrhage is not significantly different from the general population, suggesting that extensive hemostatic screening is not routinely necessary 8